U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Fine, reticulate skin pigmentation

MedGen UID:
870383
Concept ID:
C4024828
Finding
HPO: HP:0007617

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVFine, reticulate skin pigmentation

Conditions with this feature

Revesz syndrome
MedGen UID:
231230
Concept ID:
C1327916
Disease or Syndrome
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.

Recent clinical studies

Diagnosis

Belamarić M, Ljubojević Hadžavdić S
Acta Dermatovenerol Croat 2022 Dec;30(4):261-262. PMID: 36919394
Hermanns JF, Piérard GE
J Eur Acad Dermatol Venereol 2006 Mar;20(3):282-7. doi: 10.1111/j.1468-3083.2006.01426.x. PMID: 16503888
Revesz T, Fletcher S, al-Gazali LI, DeBuse P
J Med Genet 1992 Sep;29(9):673-5. doi: 10.1136/jmg.29.9.673. PMID: 1404302Free PMC Article

Prognosis

Hermanns JF, Piérard GE
J Eur Acad Dermatol Venereol 2006 Mar;20(3):282-7. doi: 10.1111/j.1468-3083.2006.01426.x. PMID: 16503888

Clinical prediction guides

Belamarić M, Ljubojević Hadžavdić S
Acta Dermatovenerol Croat 2022 Dec;30(4):261-262. PMID: 36919394
Hermanns JF, Piérard GE
J Eur Acad Dermatol Venereol 2006 Mar;20(3):282-7. doi: 10.1111/j.1468-3083.2006.01426.x. PMID: 16503888
Knight SW, Vulliamy TJ, Heiss NS, Matthijs G, Devriendt K, Connor JM, D'Urso M, Poustka A, Mason PJ, Dokal I
J Med Genet 1998 Dec;35(12):993-6. doi: 10.1136/jmg.35.12.993. PMID: 9863595Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...